Vivo Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 44

Professionals
  • Investments
  • 320

  • Portfolio
  • 81

  • Exits
  • 189

Exits

Vivo Capital General Information

Description

Founded in 1996, Vivo Capital is a venture capital firm based in Palo Alto, California. The firm seeks to invest in biopharmaceuticals, specialty pharmaceuticals, medical devices, and other subsectors of healthcare and life sciences companies.

Contact Information

Formerly Known As
BioAsia Investments
Year Founded
1996
Investor Status
Actively Seeking New Investments
Trade Association
Principles for Responsible Investment (PRI)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 192 Lytton Avenue
  • Palo Alto, CA 94301
  • United States
+1 (650) 000-0000

Vivo Capital Investments (320)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Ronovo Surgical 21-Dec-2022 Early Stage VC Surgical Devices Pre-Clinical Trials 000000 00 00.0
000000000 06-Dec-2022 00000 00000 00000 Drug Discovery Clinical Trials - Phase 3
000000 00000000000 29-Nov-2022 00000 00000 0000 Drug Discovery Generating Revenue 000000 00 00.0
00000 000000000000 15-Nov-2022 00000 00000 0000 Drug Discovery Generating Revenue
00000 07-Nov-2022 00000 00000 00000 Biotechnology Clinical Trials - Phase 2 000000 00 00.0
0000000 0000000000 02-Nov-2022 0000 0000 Drug Discovery Generating Revenue
00000000 000 24-Oct-2022 00000 00000 0000 Drug Delivery Pre-Clinical Trials
0000000 0000000000 12-Oct-2022 0000 0000 Drug Discovery Generating Revenue
Neocis 23-Sep-2022 Later Stage VC 0000 Surgical Devices Generating Revenue
Ventyx Biosciences 20-Sep-2022 PIPE 00000 Drug Discovery Generating Revenue
You’re viewing 10 of 320 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Vivo Capital Exits (189)

Company Name Exit Date Exit Type Exit Size
LEPU ScienTech 07-Nov-2022 IPO 000.00
000000000 26-Jul-2022 000000000000000000
000000 06-May-2022 000 00000
000000 30-Dec-2021 000000 0000000000 0000
00 0000000 05-Nov-2021 000 00000
0000000000 02-Nov-2021 000000 00 000000
000000 00000000000 21-Oct-2021 000 00000
00000 000000000000 10-Sep-2021 000000 0000000000 0000
Aadi Bioscience 27-Aug-2021 Reverse Merger
Sera Prognostics 15-Jul-2021 IPO 0000
You’re viewing 10 of 189 exits. Get the full list »

Vivo Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Vivo Capital‘s full profile, request access.

Request a free trial

Vivo Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Vivo Capital Team (69)

Name Title Deals Funds Boards Office
Shan Fu Co-Chief Executive Officer, Chief Executive Officer of Greater China & Managing Partner 00 0 0 Beijing, China
Daisy Xu Managing Director Palo Alto, CA
David Liu Ph.D Managing Director Palo Alto, CA
Gaurav Aggarwal MD Managing Director 0 0 0 Palo Alto, CA
Hao Dong Managing Director Palo Alto, CA
You’re viewing 5 of 69 team members. Get the full list »

Vivo Capital Co-Investors (282)

Name With Exits Lead Partner Series Industry
venBio 12 0 0 Series chart Industry bar
Cormorant Asset Management 00 0 0 Series chart Industry bar
Logos Capital 00 0 0 Series chart Industry bar
OrbiMed 00 0 0 Series chart Industry bar
RA Capital Management 00 0 0 Series chart Industry bar
You’re viewing 5 of 282 co-investors. Get the full list »